MK-0457, an Aurora kinase and BCR–ABL inhibitor, is active in patients with BCR–ABL T315I leukemia - Concepedia

Concepedia

Publication | Closed Access

MK-0457, an Aurora kinase and BCR–ABL inhibitor, is active in patients with BCR–ABL T315I leukemia

65

Citations

25

References

2012

Year

Francis J. Giles, Ronan Swords, Arnon Nagler, Andreas Hochhaus, Oliver G. Ottmann, David A. Rizzieri, Moshe Talpaz, Jason Clark, Patricia Watson, Allison G. Xiao,

Bcr–abl InhibitorTumor BiologyHematological MalignancyAurora KinaseMedicineImmunologyBcr–abl T315i LeukemiaOncologyCell BiologyCancer ResearchMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1